Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


02.07.2018

3 Ann Surg Oncol
5 BMC Cancer
2 Br J Cancer
4 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
10 Breast Cancer Res Treat
2 Cancer
3 Cancer Res
4 Clin Breast Cancer
1 Clin Exp Metastasis
4 Eur J Surg Oncol
2 Histopathology
1 Int J Oncol
2 J Clin Oncol
2 J Surg Oncol
1 JAMA
1 Mod Pathol
1 Nat Rev Clin Oncol
2 NPJ Breast Cancer
2 Oncology (Williston Park)
7 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. CHAGPAR AB, Wilke LG
    Should Reexcision Rates in Breast Cancer Care be a Quality Measure?
    Ann Surg Oncol. 2018 Jun 26. pii: 10.1245/s10434-018-6576.
    PubMed     Text format    

  2. WEBER WP, Tausch C, Hayoz S, Fehr MK, et al
    Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial.
    Ann Surg Oncol. 2018 Jun 8. pii: 10.1245/s10434-018-6556.
    PubMed     Text format     Abstract available

  3. MURPHY BL, Ray-Zack MD, Reddy PN, Choudhry AJ, et al
    Breast Cancer Litigation in the 21st Century.
    Ann Surg Oncol. 2018 Jun 28. pii: 10.1245/s10434-018-6579.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. VAN GELDERMALSEN M, Quek LE, Turner N, Freidman N, et al
    Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
    BMC Cancer. 2018;18:689.
    PubMed     Text format     Abstract available

  5. EHLERS DK, Fanning J, Salerno EA, Aguinaga S, et al
    Replacing sedentary time with physical activity or sleep: effects on cancer-related cognitive impairment in breast cancer survivors.
    BMC Cancer. 2018;18:685.
    PubMed     Text format     Abstract available

  6. HAYASHIDA T, Jinno H, Mori K, Sato H, et al
    Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial.
    BMC Cancer. 2018;18:701.
    PubMed     Text format     Abstract available

  7. ZOPPINO FCM, Guerrero-Gimenez ME, Castro GN, Ciocca DR, et al
    Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
    BMC Cancer. 2018;18:700.
    PubMed     Text format     Abstract available

  8. GREGOIRE C, Nicolas H, Bragard I, Delevallez F, et al
    Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients.
    BMC Cancer. 2018;18:677.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. CHEN S, Wang H, Li Z, You J, et al
    Interaction of WBP2 with ERalpha increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription.
    Br J Cancer. 2018 May 1. pii: 10.1038/s41416-018-0119.
    PubMed     Text format     Abstract available

  10. DERKS-SMEETS IAP, Schrijver LH, de Die-Smulders CEM, Tjan-Heijnen VCG, et al
    Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers.
    Br J Cancer. 2018 May 1. pii: 10.1038/s41416-018-0139.
    PubMed     Text format     Abstract available


    Breast Cancer

  11. PENG X, Yan B, Shen Y
    MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Breast Cancer. 2018 Jun 27. pii: 10.1007/s12282-018-0881.
    PubMed     Text format     Abstract available

  12. TAKABATAKE D, Kajiwara Y, Ohtani S, Itano Y, et al
    The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
    Breast Cancer. 2018 Jun 11. pii: 10.1007/s12282-018-0877.
    PubMed     Text format     Abstract available

  13. LIU L, Yin B, Yi Z, Liu X, et al
    Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs.
    Breast Cancer. 2018 Jun 14. pii: 10.1007/s12282-018-0880.
    PubMed     Text format     Abstract available

  14. TOYAMA T, Yoshimura A, Hayashi T, Kobayashi N, et al
    A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.
    Breast Cancer. 2018 Jun 8. pii: 10.1007/s12282-018-0879.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  15. BELLAZZO A, Sicari D, Valentino E, Del Sal G, et al
    Complexes formed by mutant p53 and their roles in breast cancer.
    Breast Cancer (Dove Med Press). 2018;10:101-112.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  16. DIECI MV, Tsvetkova V, Orvieto E, Piacentini F, et al
    Immune characterization of breast cancer metastases: prognostic implications.
    Breast Cancer Res. 2018;20:62.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  17. SMITH BL, Gadd MA, Lanahan CR, Rai U, et al
    Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.
    Breast Cancer Res Treat. 2018 Jun 9. pii: 10.1007/s10549-018-4845.
    PubMed     Text format     Abstract available

  18. BAUER ECA, Schochter F, Widschwendter P, DeGregorio A, et al
    Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment.
    Breast Cancer Res Treat. 2018 Jun 21. pii: 10.1007/s10549-018-4856.
    PubMed     Text format     Abstract available

  19. KIM JY, Lim JE, Jung HH, Cho SY, et al
    Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
    Breast Cancer Res Treat. 2018 Jun 21. pii: 10.1007/s10549-018-4858.
    PubMed     Text format     Abstract available

  20. VAN SWEARINGEN AED, Siegel MB, Deal AM, Sambade MJ, et al
    LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
    Breast Cancer Res Treat. 2018 Jun 25. pii: 10.1007/s10549-018-4852.
    PubMed     Text format     Abstract available

  21. LEE DY, Park YH, Lee JE, Choi D, et al
    Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy.
    Breast Cancer Res Treat. 2018 Jun 25. pii: 10.1007/s10549-018-4863.
    PubMed     Text format     Abstract available

  22. STOUT NK, Cronin AM, Uno H, Ozanne EM, et al
    Estrogen-receptor status and risk of contralateral breast cancer following DCIS.
    Breast Cancer Res Treat. 2018 Jun 26. pii: 10.1007/s10549-018-4860.
    PubMed     Text format     Abstract available

  23. BRENNAN M, Gass P, Haberle L, Wang D, et al
    The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer.
    Breast Cancer Res Treat. 2018 Jun 27. pii: 10.1007/s10549-018-4829.
    PubMed     Text format     Abstract available

  24. MANDUJANO-TINOCO EA, Garcia-Venzor A, Melendez-Zajgla J, Maldonado V, et al
    New emerging roles of microRNAs in breast cancer.
    Breast Cancer Res Treat. 2018 Jun 9. pii: 10.1007/s10549-018-4850.
    PubMed     Text format     Abstract available

  25. LANGBALLE R, Frederiksen K, Jensen MB, Andersson M, et al
    Mortality after contralateral breast cancer in Denmark.
    Breast Cancer Res Treat. 2018 Jun 11. pii: 10.1007/s10549-018-4846.
    PubMed     Text format     Abstract available

  26. LI X, Zhang Y, Meisel J, Jiang R, et al
    Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database.
    Breast Cancer Res Treat. 2018 Jun 15. pii: 10.1007/s10549-018-4832.
    PubMed     Text format     Abstract available


    Cancer

  27. FRANK RD, Winham SJ, Vierkant RA, Frost MH, et al
    Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31528.
    PubMed     Text format     Abstract available

  28. BAIL JR, Fruge AD, Cases MG, De Los Santos JF, et al
    A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31559.
    PubMed     Text format     Abstract available


    Cancer Res

  29. SUN R, Xie HY, Qian JX, Huang YN, et al
    FBXO22 possesses both pro-tumorigenic and anti-metastatic roles in breast cancer progression.
    Cancer Res. 2018 Jun 26. pii: 0008-5472.CAN-17-3647.
    PubMed     Text format     Abstract available

  30. ZHANG W, Wu M, Chong QY, Zhang M, et al
    Loss of estrogen-regulated MIR135A1 at 3p21.1 promotes tamoxifen resistance in breast cancer.
    Cancer Res. 2018 Jun 26. pii: 0008-5472.CAN-18-0069.
    PubMed     Text format     Abstract available

  31. IM YK, Najyb O, Gravel SP, McGuirk S, et al
    Interplay between ShcA signaling and PGC-1alpha triggers targetable metabolic vulnerabilities in breast cancer.
    Cancer Res. 2018 Jun 21. pii: 0008-5472.CAN-17-3696.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  32. CHEN M, Pockaj B, Andreozzi M, Barrett MT, et al
    JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780.
    PubMed     Text format     Abstract available

  33. MORI H, Kubo M, Kai M, Velasquez VV, et al
    BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.
    Clin Breast Cancer. 2018 Jun 2. pii: S1526-8209(18)30022.
    PubMed     Text format     Abstract available

  34. SIOTOS C, McColl M, Psoter K, Gilmore RC, et al
    Tumor Site and Breast Cancer Prognosis.
    Clin Breast Cancer. 2018 May 29. pii: S1526-8209(18)30299.
    PubMed     Text format     Abstract available

  35. KIM Y, Sim SH, Park B, Lee KS, et al
    Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
    Clin Breast Cancer. 2018 Jun 7. pii: S1526-8209(18)30300.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  36. YANG YX, Wei L, Zhang YJ, Hayano T, et al
    Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
    Clin Exp Metastasis. 2018 Jun 8. pii: 10.1007/s10585-018-9901.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  37. HARTMANN S, Reimer T, Gerber B, Stubert J, et al
    Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.
    Eur J Surg Oncol. 2018 Jun 9. pii: S0748-7983(18)31119.
    PubMed     Text format     Abstract available

  38. RAFNSDOTTIR SL, Audisio RA
    Inflammatory Breast Cancer: What surgeons need to know.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31128.
    PubMed     Text format     Abstract available

  39. AUDISIO RA
    Inflammatory Breast Cancer: Updates on diagnosis and treatment options.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31123.
    PubMed     Text format    

  40. ALTUNDAG K
    Locally advanced non-inflammatory breast cancer may be misdiagnosed as inflammatory breast cancer.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31122.
    PubMed     Text format    


    Histopathology

  41. ALTHOBITI M, Aleskandarany MA, Joseph C, Toss M, et al
    Heterogeneity of Tumour Infiltrating Lymphocytes (TILs) in Breast Cancer and its prognostic significance.
    Histopathology. 2018 Jun 27. doi: 10.1111/his.13695.
    PubMed     Text format     Abstract available

  42. PUCCETTI M, Ravaioli S, Tumedei MM, Bucchi E, et al
    Are FNAB-derived cell blocks a useful surrogate for tissue samples in breast cancer?
    Histopathology. 2018 Jun 26. doi: 10.1111/his.13694.
    PubMed     Text format     Abstract available


    Int J Oncol

  43. HAN W, Cao F, Gao XJ, Wang HB, et al
    ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Int J Oncol. 2018 Jun 21. doi: 10.3892/ijo.2018.4450.
    PubMed     Text format     Abstract available


    J Clin Oncol

  44. RAMAKRISHNA N, Temin S, Chandarlapaty S, Crews JR, et al
    Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
    J Clin Oncol. 2018 Jun 25:JCO2018792713. doi: 10.1200/JCO.2018.79.2713.
    PubMed     Text format     Abstract available

  45. GIORDANO SH, Temin S, Chandarlapaty S, Crews JR, et al
    Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.
    J Clin Oncol. 2018 Jun 25:JCO2018792697. doi: 10.1200/JCO.2018.79.2697.
    PubMed     Text format     Abstract available


    J Surg Oncol

  46. FUJIMOTO Y, Higuchi T, Nishimukai A, Miyagawa Y, et al
    High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25125.
    PubMed     Text format     Abstract available

  47. VOLDERS JH, Negenborn VL, Haloua MH, Krekel NMA, et al
    Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
    J Surg Oncol. 2018;117:1001-1008.
    PubMed     Text format     Abstract available


    JAMA

  48. GILL J, Obley AJ, Prasad V
    Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    JAMA. 2018;319:2377-2378.
    PubMed     Text format    


    Mod Pathol

  49. SONBUL SN, Aleskandarany MA, Kurozumi S, Joseph C, et al
    Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.
    Mod Pathol. 2018 Jun 28. pii: 10.1038/s41379-018-0092.
    PubMed     Text format     Abstract available


    Nat Rev Clin Oncol

  50. SIDAWAY P
    Ribociclib effective in HR(+), HER2(-) breast cancer.
    Nat Rev Clin Oncol. 2018 Jun 21. pii: 10.1038/s41571-018-0059.
    PubMed     Text format    


    NPJ Breast Cancer

  51. WILLIAMS LA, Butler EN, Sun X, Allott EH, et al
    TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
    NPJ Breast Cancer. 2018;4:13.
    PubMed     Text format     Abstract available

  52. TANGUY ML, Cabel L, Berger F, Pierga JY, et al
    Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer.
    NPJ Breast Cancer. 2018;4:14.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  53. MITCHELL MP, Sharma P
    The Use of Surgery and Radiotherapy as Treatment of Regional Nodes in Breast Cancer Patients.
    Oncology (Williston Park). 2018;32:e52-e64.
    PubMed     Text format     Abstract available

  54. STOEN E, Kabos P, Borden KC, Brown RJ, et al
    A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.
    Oncology (Williston Park). 2018;32:298-302.
    PubMed     Text format    


    PLoS One

  55. BOYNE DJ, King WD, Brenner DR, McIntyre JB, et al
    Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial.
    PLoS One. 2018;13:e0198641.
    PubMed     Text format     Abstract available

  56. LOBBA ARM, Carreira ACO, Cerqueira OLD, Fujita A, et al
    High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
    PLoS One. 2018;13:e0199254.
    PubMed     Text format     Abstract available

  57. MARTIN CL, Tate DF, Valle CG
    Nonadherence to daily self-weighing and activity tracking is associated with weight fluctuations among African American breast cancer survivors.
    PLoS One. 2018;13:e0199751.
    PubMed     Text format     Abstract available

  58. VOUTOURI C, Stylianopoulos T
    Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    PLoS One. 2018;13:e0193801.
    PubMed     Text format     Abstract available

  59. HORIE Y, Makihara H, Horikawa K, Takeshige F, et al
    Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes.
    PLoS One. 2018;13:e0193830.
    PubMed     Text format     Abstract available

  60. GODLEWSKA M, Krasuska W, Czarnocka B
    Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines.
    PLoS One. 2018;13:e0193624.
    PubMed     Text format     Abstract available

  61. LESICKA M, Jablonska E, Wieczorek E, Seroczynska B, et al
    Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.
    PLoS One. 2018;13:e0199622.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: